11 results about "Siegesbeckia orientalis" patented technology

This invention relates to the field of traditional Chinese medicine (TCM) technology, and more particularly to the application of TCM compositions in the preparation of drugs for the prevention and treatment of diabetes. The TCM composition of this invention includes *Sedum sarmentosum*, seaweed, oyster shell, hawthorn, *Siegesbeckia orientalis*, *Schisandra chinensis*, and *Polygonum cuspidatum*. This invention has found that this composition can significantly reduce blood glucose levels in type 2 diabetic rats and increase serum insulin levels and insulin sensitivity index in rats. Moreover, the compound combination drug for treating diabetes is an existing TCM preparation, safe to use, and its preparation method is simple, rapid, efficient, and easy to operate. The prepared mixtures, tablets, capsules, and micro-pills are easy to carry and convenient to take.

The invention provides a traditional Chinese medicine composition which comprises the following components in parts by weight: 32-34 parts of rumex hanus, 20-31 parts of dandelion, 20-32 parts of uncaria rhynchophylla and 15-35 parts of gastrodia elata. And at least one of the following six traditional Chinese medicines in parts by weight: 17-37 parts of radix paeoniae alba, 15-20 parts of lumbricus, 10-45 parts of eucommia ulmoides, 22-34 parts of longan seeds, 20-37 parts of tribulus terrestris and 10-30 parts of herba siegesbeckiae. The traditional Chinese medicine composition is taken by adopting deuterium-depleted water. The combination of the traditional Chinese medicinal materials has a synergistic effect in the aspects of treating hypertension, hyperlipidemia and metabolic syndrome, the traditional Chinese medicinal materials respectively contain different active ingredients, the overall curative effect is enhanced by regulating blood pressure, blood fat and metabolic functions through multiple targets, and in order to enable the traditional Chinese medicinal composition to better exert the drug effect, the traditional Chinese medicinal composition has a remarkable curative effect. Preferably, the deuterium-depleted water is matched with the traditional Chinese medicine composition to be taken, and the effect of the deuterium-depleted water is developed by 1-2 times.

The application discloses a traditional Chinese medicine composition for treating rheumatoid arthritis. The traditional Chinese medicine composition is composed of the following raw medicinal materials in parts by weight: coix seed 50-70 parts, quassia 50-70 parts, siegesbeckia orientalis 25-35 parts, melon seed 25-35 parts, radix rehmanniae 25-35 parts, atractylodes 25-35 parts, raw licorice 8-12 parts and amomum villosum 8-12 parts. The traditional Chinese medicine composition has the effects of clearing heat and removing dampness, dredging collaterals and relieving arthralgia, invigorating the spleen and tonifying the body, nourishing yin and nourishing blood, can significantly improve the clinical symptoms of rheumatoid arthritis patients, has high safety, and is suitable for long-term use.

The invention discloses a traditional Chinese medicine composition for treating osteoarthritis, and belongs to the technical field of traditional Chinese medicines. In the traditional Chinese medicine composition, monarch drugs are radix angelicae pubescentis and processed semen strychni; ministerial drugs comprise radix aconiti preparata, tripterygium wilfordii, radix clematidis and rhizoma drynariae; the adjuvant drugs comprise kadsura pepper stem, liquidambar formosana hance, pawpaw, rhizoma dioscoreae nipponicae, frankincense, ground beetle, herba epimedii, teasel root, herba siegesbeckiae and lycopodium clavatum; and the conductant drug is coix seed. The whole formula is monarch, minister, assistant and guide, cooperates with each other, is rigorous in formula, has the effects of dispelling wind and eliminating dampness, warming channels and expelling cold, removing stasis and diminishing swelling, relaxing tendons and dredging collaterals, and tonifying kidney and strengthening liver, can remove arthralgia of knee and ankle joints and recover functions, can be used for treating osteoarthritis, and has a wide application prospect.

The invention relates to a medicine for treating cerebral thrombosis, cerebral thrombosis precursor and cerebral thrombosis sequelae. Comprising the following raw materials in parts by weight: 15-30 parts of astragalus membranaceus, 10-20 parts of ligusticum wallichii, 10-20 parts of radix paeoniae rubra, 10-20 parts of gastrodia elata, 2-5 parts of scorpion, 10-20 parts of pseudo-ginseng, 10-20 parts of rhizoma corydalis, 10-20 parts of radix clematidis, 10-20 parts of earthworm, 10-20 parts of honeysuckle stem, 10-20 parts of ginkgo leaf, 1-3 parts of centipede, 10-20 parts of cassia twig, 2-5 parts of leech and 10-20 parts of herba siegesbeckiae. The traditional Chinese medicine is orally taken and externally applied, and has the effects of dispersing blood stasis, relieving spasm, activating blood, relieving pain, tonifying qi and nourishing blood.

This invention provides a topical herbal patch for postpartum acute mastitis and its preparation method, belonging to the field of traditional Chinese medicine pharmaceutical technology. The patch is composed of *Paris polyphylla*, *Vaccaria segetalis*, *Uncaria rhynchophylla*, *Bombyx mori*, *Mild Glauber's salt*, processed *Evodia rutaecarpa*, *Citrus aurantium*, *Cirsium japonicum*, *Smilax china*, *Siegesbeckia orientalis*, stir-fried *Melia azedarach*, and licorice. Based on a rigorous formula of principal, assistant, and adjuvant herbs, this patch significantly reduces serum TNF-α, IL-1β, and IL-6 levels in mice with postpartum mastitis, and significantly improves the overall clinical efficacy. It rapidly relieves core symptoms such as breast redness, swelling, pain, and induration, clears milk stasis, and possesses multiple effects including anti-inflammatory, anti-swelling, lactation-promoting, and analgesic properties. This herbal patch is a topical care preparation that acts directly on the affected area of ​​the breast. The drug is absorbed transdermally without gastrointestinal metabolism, and its components do not affect the infant through breast milk. This provides a safe, efficient, and convenient new topical care solution for postpartum acute mastitis.

This invention relates to the field of traditional Chinese medicine (TCM) technology, and particularly to the application of TCM compositions in the preparation of drugs for the prevention and treatment of nephrotic syndrome. The TCM composition of this invention includes *Sedum sarmentosum*, seaweed, oyster shell, hawthorn, *Siegesbeckia orientalis*, *Schisandra chinensis*, and *Polygonum cuspidatum*. This invention has found that this composition can significantly reduce urinary protein levels, regulate serum ALB, Cr, and BUN levels, improve renal function, and has a good therapeutic effect on nephrotic syndrome. Moreover, this TCM composition is an existing prepared Chinese medicine, safe to use, and its preparation method is simple, rapid, efficient, and easy to operate. The prepared mixtures, tablets, capsules, and micro-pellets are easy to carry and convenient to take.

The invention discloses a traditional Chinese medicine composition for treating animal damp obstruction and collateral obstruction syndrome as well as a preparation method and application thereof, and belongs to the technical field of traditional Chinese veterinary medicines. The traditional Chinese medicine composition is prepared from the following components: spica prunellae, semen coicis, herba leonuri, radix astragali seu hedysari, pine needle, fructus ligustri lucidi, folium ilicis cornutae, herba geranii, radix salviae miltiorrhizae, herba siegesbeckiae, radix stephaniae tetrandrae, radix angelicae sinensis, rhizoma smilacis glabrae, herba lycopi, radix According to a traditional Chinese medicine compatibility theory formula, the effective composition for treating the animal damp obstruction collateral obstruction syndrome is provided for protecting animal health, and the traditional Chinese medicine composition has the effects of promoting diuresis and excreting dampness, relieving arthralgia and pain, tonifying liver and kidney and strengthening spleen, and can be used for treating dysplasia, arthrocele, chest cyst and production performance reduction caused by the damp obstruction collateral obstruction syndrome.

The invention discloses a traditional Chinese medicine pill for treating postpartum rheumatism with internal heat and external cold. The traditional Chinese medicine pill for treating postpartum rheumatism with internal heat and external cold comprises the following components in parts by weight: 2-3 parts of black-bone chicken, 2 parts of albizia flower, 2 parts of radix clematidis, 2 parts of herba siegesbeckiae and 1-2 parts of lycopodium clavatum. According to the traditional Chinese medicine pill for treating postpartum rheumatism with internal heat and external cold, the black-bone chicken, the albizia flower, the radix clematidis, the herba siegesbeckiae and the lycopodium clavatum are processed in proportion to prepare the traditional Chinese medicine pill, the postpartum rheumatism with internal heat and external cold can be effectively treated, a patient can be helped to recover health more quickly, and the traditional Chinese medicine pill is more suitable for long-term storage and has no toxic or side effect. The traditional Chinese medicine pill is more convenient to use and is more beneficial to use at home.

This invention discloses the application of the Siegesbeckia orientalis composition in the preparation of drugs to improve cognitive impairment after heart failure (CHF). The composition consists of Astragalus membranaceus extract, Siegesbeckia orientalis extract, and Periploca sepium extract. Experiments have shown that the Siegesbeckia orientalis composition can significantly improve spatial memory and working memory in CHF rats, and improve cognitive function; it can significantly inhibit the release of tumor necrosis factor α and interleukin 1β in the hippocampus of CHF rats, and increase the release of interleukin 10 and brain-derived neurotrophic factor; it can significantly reduce the loss and damage of Nissl bodies in the brain tissue of CHF rats; and it can significantly improve the ultrastructure of neurons in the hippocampus of CHF rats, regulate synaptic plasticity, and promote the growth of dendrites and dendritic spines.

The invention relates to the technical field of traditional Chinese medicine, in particular to a traditional Chinese medicine composition capable of being combined with acupuncture to treat scapulohumeral periarthritis, a preparation and application of the traditional Chinese medicine composition. The composition is prepared from the following medicinal materials in parts by weight: 15 to 30 parts of rhizoma chuanxiong, 20 to 30 parts of rhizoma curcumae longae, 15 to 30 parts of peach kernel, 15 to 30 parts of flos carthami, 10 to 20 parts of pericarpium citri reticulatae viride processed with vinegar, 10 to 20 parts of rhizoma corydalis, 5 to 10 parts of radix aconiti lateralis preparata, 10 to 15 parts of cortex cinnamomi, 3 to 6 parts of herba asari, 20 to 30 parts of cortex erythrinae, 20 to 30 parts of herba siegesbeckiae, 15 to 25 parts of lignum sappan, 10 to 20 parts of semen brassicae, 15 to 25 parts of ramulus mori and 10 to 15 parts of radix glycyrrhizae. The invention provides a brand-new traditional Chinese medicine composition capable of treating scapulohumeral periarthritis by combining acupuncture, a preparation and application thereof, the traditional Chinese medicine composition is combined with acupuncture, and pain, stiffness and limited activity of scapulohumeral periarthritis can be synergistically improved by internally regulating qi and blood and externally dredging meridians and collaterals. A novel traditional Chinese medicine treatment thought is provided for clinical treatment of the scapulohumeral periarthritis disease.